Slide 1: JENOPTIK AG – First nine months 2025
JENOPTIK AG – First nine months 2025 Dr. Stefan Traeger I Dr. Prisca Havranek-Kosicek | November 12, 2025 © Copyright Jenoptik. All rights reserved.
Slide 2: Disclaimer
Disclaimer This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the
Slide 3: First nine months 2025 at a glance
First nine months 2025 at a glance
Slide 4: Continued acceleration of demand, market environment remains uncertain
Continued acceleration of demand, market environment remains uncertain Business highlights: Semiconductor & − Order intake almost reached prior-year level Advanced Manufacturing − Revenue and EBITDA below prior year, as expected; positive development over the course of the year − Free cash flow sign
Slide 5: First nine months 2025 Group and Strategic Business Units
First nine months 2025 Group and Strategic Business Units
Slide 6: Order intake almost at prior-year level, substantial improvement in demand in the course of the year
Order intake almost at prior-year level, substantial improvement in demand in the course of the year Order intake in MEUR −0.6% 800 781.9 777.3 In million euros 9M/2025 9M/2024 Change in % 257.4 304.5 Semiconductor & Advanced Manufacturing 297.6 364.7 −18.4 Q3 Biophotonics 213.2 159.0 34.2 600 Metro
Slide 7: Revenue in first nine months influenced by challenging environment
Revenue in first nine months influenced by challenging environment Revenue in MEUR 1000 In million euros 9M/2025 9M/2024 Change in % − 7.6% Semiconductor & Advanced Manufacturing 314.9 371.2 −15.2 815.1 Biophotonics 182.1 160.7 13.4 753.2 750 274.3 Metrology & Production Solutions 139.0 156.7 −11.3
Slide 8: EBITDA down on lower revenue and product mix effects; EBITDA margin at 17.5% vs. 19.7% in prior year
EBITDA down on lower revenue and product mix effects; EBITDA margin at 17.5% vs. 19.7% in prior year EBITDA in MEUR EBITDA in million euros EBITDA margin in % 200 9M/2025 9M/2024 9M/2025 9M/2024 − 17.9% 160.6 Semiconductor & Advanced 160 Manufacturing 78.2 111.4 24.1 29.6 59.1 131.8 Biophotonics 39.
Slide 9: Program to reduce personnel and material expenses largely implemented; earnings did not reach prior-year level
Program to reduce personnel and material expenses largely implemented; earnings, however, did not reach prior-year level In million euros 9M/2025 9M/2024 Change in % − Gross margin influenced in particular by lower Revenue 753.2 815.1 −7.6 contribution of Semiconductor & Advanced Manufacturing Gross
Slide 10: Balance sheet ratios and liquidity situation remain solid
Balance sheet ratios and liquidity situation remain solid In million euros 9M/2025 9M/2024 Change in % − Cash flows from operating activities: reduction Cash flows from operating activities (prior year increase) in working capital more than offset 139.7 124.9 11.8 before income taxes lower earnings
Slide 11: Outlook
Outlook
Slide 12: Guidance further specified: Targets 2025 and future development
Guidance further specified Targets 2025 and future development − Revenue at lower end of guidance range (between prior-year figure and minus 5% / 2024: 1,115.8 million euros) − EBITDA margin at lower end of guidance range incl. expected expenses for cost reduction measures in high single-digit milli
Slide 13: Appendix
Appendix
Slide 14: Streamlined organizational structure implemented to enhance customer focus and efficiency
Streamlined organizational structure implemented to enhance customer focus and efficiency Jenoptik has become more simple − Matrix structure largely removed in 2024 Stronger customer focus, more − Full allocation of plants to individual efficiency clearer responsibilities Strategic Business Units Se
Slide 15: New organizational and reporting structure
New organizational and reporting structure Semiconductor & Metrology & Smart Mobility Advanced Biophotonics Production Solutions Manufacturing Solutions − Optical and micro-optical − Optical components for − Systems and service for − Camera systems and components for the life science & medical inspe
Slide 16: Reconciliation of group reporting
Reconciliation of group reporting Structure since Semiconductor Metrology & Global Group 1.1.2025 Smart Mobility Functions / & Advanced Biophotonics Production Solutions Prodomax Manufacturing Solutions HOMMEL Prodomax Structure until ETAMIC 31.12.2024 Smart Mobility Advanced Photonic Solutions Non-
Slide 17: Dates and contact
Dates and contact 12.11.2025 Publication 9M/2025 13.11.2025 Morgan Stanley Conference, Barcelona (CEO/IR) 13.11.2025 LBBW Conference (virtual) (CFO/IR) 18.11.2025 BNP Paribas Exane Conference, Paris (CFO/IR) 25.11.2025 Eigenkapitalforum, Frankfurt/Main (IR) 02.12.2025 Berenberg European Conference,